Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report
In Vivo · 2025
DOI: 10.21873/invivo.14165 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, 2025. Verfasst von Chin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Immunomodulation, Hydrogen, Lupus Erythematosus, Systemic, Pulmonary Arterial Hypertension. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Pulmonary arterial hypertension (PAH) is a severe complication of systemic lupus erythematosus (SLE), marked by vascular remodeling, immune dysregulation, and progressive right heart failure. Molecular hydrogen therapy, a selective antioxidant and anti-inflammatory agent, has the capacity to modulate immune responses in these autoimmune disease patients. This case report details the clinical improvement in an SLE patient with PAH after starting adjunctive hydrogen capsule therapy, highlighting its potential as a novel approach for this challenging complication. CASE REPORT: A 45-year-old Taiwanese woman with SLE-PAH who received hydrogen capsule therapy, during which serial immunophenotyping revealed dynamic changes in T cell exhaustion markers, regulatory T cell (Treg) subsets, and regulatory B cells (Breg). Notably, KLRG1+ T cells and CD39+Helios- Tregs were suppressed during therapy but rebounded after cessation, suggesting transient immune suppressing followed by regulatory rebalancing. Bregs also showed a similar pattern, declining during therapy and recovering after discontinuation. CONCLUSION: These findings suggest a biphasic immunomodulatory effect of hydrogen therapy, that is, initially dampening immune activation, followed by a regulatory rebound after hydrogen therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, R.O.C.
- Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
- The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
- School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.
Zitieren
APA
Liu, C., Lu, J. W., Wu, C. H., Ho, Y. J., Lui, S. W., Hsieh, T. Y., Wang, K. Y., & Liu, F. C. (2025). Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report. In Vivo. https://doi.org/10.21873/invivo.14165
Vancouver
Liu C, Lu JW, Wu CH, Ho YJ, Lui SW, Hsieh TY, et al. Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report. In Vivo. 2025. doi:10.21873/invivo.14165
BibTeX
@article{Liu2025,
author = {Liu, Chin and Lu, Jeng-Wei and Wu, Chun-Hsien and Ho, Yi-Jung and Lui, Shan-Wen and Hsieh, Ting-Yu and Wang, Kuang-Yih and Liu, Feng-Cheng},
title = {Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14165}
}
EUVIMED